Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Suven Pharmaceuticals Ltd - 543064 - Board Meeting Intimation for Intimation Of Board Meeting Of The Company To Be Held On Saturday, The 6Th November, 2021

 Suven Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2021 ,inter alia, to consider and approve To consider and approve the Un-Audited Financial Results (Standalone and Consolidated) of the Company under Ind AS for the second quarter and half-year ending September 30, 2021 and related matters.
29-10-2021
Bigul

Suven Pharmaceuticals Ltd - 543064 - Statement Of Investor Complaints For The Quarter Ended September 2021

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 019190 Name of the Signatory :- K Hanumantha RaoDesignation :- Company Secretary and Compliance Officer
20-10-2021
Bigul

Suven Pharmaceuticals Ltd - 543064 - Shareholding for the Period Ended September 30, 2021

 Suven Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here
12-10-2021
Bigul

Suven Pharmaceuticals Ltd - 543064 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018, please find enclosed herewith the Confirmation Certificates issued by KFin Technologies Private Limited, Registrar and Share Transfer Agents of the Company, for the quarter ended September 30, 2021.
11-10-2021
Bigul

Suven Pharmaceuticals Ltd - 543064 - Closure of Trading Window

 We wish to inform you that the "Trading Window" for dealing in the securities of the Company will be closed for the Designated Persons, their immediate relatives covered under the said Code of the Company from 01st October, 2021 and the same will remain closed till 48 hours after the declaration of Financial Results for the quarter ending on 30th September, 2021, to the public, in terms of the Code of Conduct of the Company under the SEBI (Prohibition of Insider Trading) Regulations, 2015. This is for your information and record.
30-09-2021

Suven Pharma promoter sells Jubilee Hills property in Hyderabad for Rs 34.75 crore

 The property, located in posh Jubilee Hills area, attracted a stamp duty of Rs 2.64 crore
29-09-2021
Bigul

Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 With reference to the subject, the schedule of investor meeting with the Company is given below: Management of Suven Pharmaceuticals Limited is participating in IDEATION SERIES, virtual conference conducted by B&K; securities, Mumbai at 4:45 to 5:30pm on 22 Sept 2021. Discussion will be on the Company specific information including Financial Results which were already in public domain. This is for your information and record.
22-09-2021
Bigul

Suven Pharmaceuticals Ltd - 543064 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Suven Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
01-09-2021
Bigul

Suven Pharmaceuticals Ltd - 543064 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

 This is with reference to our earlier letter dated 6th August, 2021 regarding the 3rd Annual General Meeting (AGM) of the Company held today i.e. August 31, 2021 and the businesses mentioned in the Notice dated July 23, 2021 was transacted. In this regard, please find enclosed the following: 1. Summary of proceedings as required under the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as Annexure - I 2. Voting Results as required under Regulation 44 of the SESI (Listing Obligations and Disclosure Requirements) Regulations 2015 as Annexure- II 3. The Report of Scrutinizer on remote e-voting and voting at AGM (by electronic means) as Annexure- III We request you to take the documents on your record.
31-08-2021
Bigul

Suven Pharmaceuticals Ltd - 543064 - Shareholder Meeting / Postal Ballot-Outcome of AGM

 This is with reference to our earlier letter dated 6th August, 2021 regarding the 3rd Annual General Meeting (AGM) of the Company held today i.e. August 31, 2021 and the businesses mentioned in the Notice dated July 23, 2021 was transacted. In this regard, please find enclosed the following: 1. Summary of proceedings as required under the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as Annexure - I 2. Voting Results as required under Regulation 44 of the SESI (Listing Obligations and Disclosure Requirements) Regulations 2015 as Annexure- II 3. The Report of Scrutinizer on remote e-voting and voting at AGM (by electronic means) as Annexure- III We request you to take the documents on your record.
31-08-2021
Next Page
Close

Let's Open Free Demat Account